全文获取类型
收费全文 | 3561篇 |
免费 | 295篇 |
国内免费 | 108篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 87篇 |
妇产科学 | 41篇 |
基础医学 | 554篇 |
口腔科学 | 61篇 |
临床医学 | 439篇 |
内科学 | 804篇 |
皮肤病学 | 59篇 |
神经病学 | 217篇 |
特种医学 | 249篇 |
外科学 | 527篇 |
综合类 | 54篇 |
一般理论 | 1篇 |
预防医学 | 226篇 |
眼科学 | 63篇 |
药学 | 319篇 |
中国医学 | 1篇 |
肿瘤学 | 207篇 |
出版年
2021年 | 39篇 |
2020年 | 37篇 |
2019年 | 41篇 |
2018年 | 74篇 |
2017年 | 53篇 |
2016年 | 62篇 |
2015年 | 83篇 |
2014年 | 72篇 |
2013年 | 116篇 |
2012年 | 130篇 |
2011年 | 146篇 |
2010年 | 100篇 |
2009年 | 114篇 |
2008年 | 145篇 |
2007年 | 173篇 |
2006年 | 140篇 |
2005年 | 134篇 |
2004年 | 133篇 |
2003年 | 124篇 |
2002年 | 122篇 |
2001年 | 104篇 |
2000年 | 126篇 |
1999年 | 101篇 |
1998年 | 84篇 |
1997年 | 61篇 |
1996年 | 71篇 |
1995年 | 46篇 |
1994年 | 53篇 |
1993年 | 41篇 |
1992年 | 78篇 |
1991年 | 78篇 |
1990年 | 65篇 |
1989年 | 72篇 |
1988年 | 71篇 |
1987年 | 66篇 |
1986年 | 62篇 |
1985年 | 52篇 |
1984年 | 54篇 |
1983年 | 38篇 |
1982年 | 21篇 |
1980年 | 29篇 |
1979年 | 35篇 |
1978年 | 28篇 |
1977年 | 24篇 |
1976年 | 29篇 |
1975年 | 28篇 |
1974年 | 38篇 |
1973年 | 27篇 |
1972年 | 26篇 |
1971年 | 27篇 |
排序方式: 共有3964条查询结果,搜索用时 10 毫秒
1.
J Finsterer E-W Kues S Brunner 《The European journal of contraception & reproductive health care》2006,11(3):237-240
OBJECTIVES: Pseudotumour cerebri has been previously recognized as a neurological side effect of combined oral contraceptives but has not been diagnosed with a delay of 3 years after initiation of combined oral contraceptives. CASE REPORT: A 19-year-old obese woman developed visual impairment and headache, 4 months after starting combined oral contraceptives. Three years later symptoms deteriorated and she presented with prominent tendon-jerks and congested optical-discs. Normal CSF drained with high pressure from the spinal tap. Pseudotumour cerebri was diagnosed. Headache and visual impairment resolved within 3 weeks after discontinuation of combined oral contraceptives. CONCLUSIONS: Combined oral contraceptives-induced pseudotumour cerebri may remain undetected for years. Young, obese women with visual impairment and headache under combined oral contraceptives should undergo immediate neurological and ophthalmological investigation. 相似文献
2.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
3.
4.
G Tufveson W Geelings M Broyer F P Brunner H Brynger S R Dykes J H Ehrich W Fassbinder G Rizzoni N H Selwood 《Nephrology, dialysis, transplantation》1989,4(3):161-171
This paper summarises the information given on the 1986 EDTA Registry centre questionnaire which was returned by 82% of the 2,065 known dialysis and transplant centres in 33 European countries. Information is given on the number of patients alive on haemodialysis according to the type of dialysis facilities available where the patient was receiving dialysis and the number of patients receiving special types of dialysis. The centre questionnaire also included questions on testing for HIV infection, serological evidence or symptoms of AIDS and the diagnosis of hepatitis B in patients and staff. The data given in response to these questions are presented together with data on the involvement of dietitians and social workers in the treatment of patients with end stage renal failure. Finally, information on transplant activity in Europe and the treatment policies of transplanting centres is provided. 相似文献
5.
Binet I; Bock A; Vogelbach P; Gasser T; Kiss A; Brunner F; Thiel G 《Nephrology, dialysis, transplantation》1997,12(9):1940-1948
Background. The growing shortage of cadaver kidneys,
the limited possibilities to expand the living related donor pool and the
good results obtained in our centre with poorly matched cadaver kidneys,
led us in 1991 to begin accepting highly motivated, unrelated, living
kidney donors who had a strong emotional bond with the recipients.
Methods. Between 1 January 1991 and 1 January 1996, 46
potential living kidney donors and their emotionally related recipients
were evaluated. Twenty-three cases were accepted for renal transplantation
after thorough somatic and psychological evaluation. The mean
post-transplant follow-up until 1 April 1996 was of 28±3 months.
Compatible blood groups and a negative cross-match were mandatory, but no
minimal HLA matching was required. Results. There was
a 50% drop-out rate following the initial screening. The main reasons for
not performing transplantation were immunological contraindications in 39%
of the cases, somatic in 30.5%, psychological in 26% and socioeconomic in
4.5%. In the accepted group of recipients, 48% (11/23) received transplants
without chronic dialysis. Donor survival was 91%; two deaths unrelated to
nephrectomy occurred 1 year after donation. The 2-year actuarial recipient
and graft survivals were 100% and 91% respectively, compared to 99%
(recipients) and 93% (grafts) in the non-HLA-identical living related
kidney transplant group, and to 93% (recipients) and 83% (grafts) in the
cadaver kidney transplant group. Recipient rehabilitation was completed
after 4±1 months. Emotionally related donors returned to work
5±2 weeks after nephrectomy, and no donor regretted his
decision, even in the case of failure. Conclusions.
Kidney transplantation from emotionally related living donors represents a
valuable option, allowing more patients with end-stage renal disease to
avoid chronic dialysis. Recipient and graft outcome were superior to
cadaver kidney transplantation. Motivated and emotionally related donors
should be allowed to donate one of their kidneys provided that they are
carefully selected and thoroughly informed. 相似文献
6.
7.
8.
J B van de Biezenbos J G Nijhuis H G Brunner 《Nederlands tijdschrift voor geneeskunde》1992,136(50):2480-2482
We describe the maternal and neonatal complications of pregnancy in two patients with myotonic dystrophy. The disease leads to an increased spontaneous abortion rate, hydramnios, prolonged first and second stages of labour, retained placenta, postpartum haemorrhages and anaesthetic sensitivity in the mother. The neonatal problems are caused by the congenital form of the disease. The major clinical features of congenital myotonic dystrophy are bilateral facial weakness, hypotonia, neonatal distress, feeding difficulties, talipes, tent-shaped mouth, mental retardation and delayed motor development. Relatives of a known myotonic dystrophy patient should be advised to let themselves be examined for this disease. If the disease is diagnosed, information should be given regarding possibilities for prenatal diagnosis. Pregnancy in myotonic dystrophy patients should be monitored by a gynaecologist. Labour has to take place in a hospital with intensive care facilities for mother and child. 相似文献
9.
10.